首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   402161篇
  免费   27744篇
  国内免费   4861篇
耳鼻咽喉   5451篇
儿科学   8460篇
妇产科学   10294篇
基础医学   55431篇
口腔科学   12140篇
临床医学   33088篇
内科学   81030篇
皮肤病学   8816篇
神经病学   28532篇
特种医学   14950篇
外国民族医学   89篇
外科学   63076篇
综合类   15627篇
现状与发展   9篇
一般理论   65篇
预防医学   19321篇
眼科学   9987篇
药学   33928篇
  20篇
中国医学   3837篇
肿瘤学   30615篇
  2021年   3596篇
  2020年   2684篇
  2019年   3612篇
  2018年   5411篇
  2017年   4306篇
  2016年   4280篇
  2015年   5191篇
  2014年   7275篇
  2013年   8893篇
  2012年   12097篇
  2011年   12455篇
  2010年   7900篇
  2009年   7208篇
  2008年   10984篇
  2007年   11820篇
  2006年   11685篇
  2005年   10509篇
  2004年   9746篇
  2003年   9595篇
  2002年   9045篇
  2001年   28921篇
  2000年   29356篇
  1999年   24031篇
  1998年   5291篇
  1997年   4312篇
  1996年   3834篇
  1995年   3606篇
  1994年   3222篇
  1993年   2910篇
  1992年   16089篇
  1991年   14872篇
  1990年   14199篇
  1989年   14000篇
  1988年   12615篇
  1987年   12077篇
  1986年   11122篇
  1985年   10334篇
  1984年   6921篇
  1983年   5600篇
  1982年   2716篇
  1979年   5476篇
  1978年   3345篇
  1977年   2963篇
  1975年   2636篇
  1974年   3064篇
  1973年   2863篇
  1972年   2828篇
  1971年   2773篇
  1970年   2509篇
  1969年   2543篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
31.
精神分裂症的主观生活质量反映了患者对个人身体、心理、社会和行为功能的满意度,为 精神卫生系统提供了一个评价临床疗效的主观指标。现回顾精神分裂症主观生活质量的评估工具和影 响因素,为改善患者主观生活质量的实践提供参考  相似文献   
32.
目的 基于基因组Survey分析对刺果甘草Glycyrrhiza pallidiflora Maxim.基因组大小和杂合率进行估计,并通过叶绿体基因组序列特征对其在甘草属Glycyrrhiza L.中的系统发育位置进行研究。方法 使用二代测序技术对刺果甘草进行测序,采用K-mer方法对测序reads进行分析,估算刺果甘草基因组大小和杂合率,使用生物信息学方法进行叶绿体基因组组装、注释和系统发育分析。结果 Survey分析结果显示其基因组大小约为577.82 Mb,杂合度约为0.31%,重复序列比例约为53.72%。叶绿体基因组长度为127,267 bp,不具有典型的四分体结构,总GC含量为34.32%,包含110个基因,其中76个蛋白质编码基因,30个tRNA基因和4个rRNA基因。系统发育分析表明,刺果甘草与圆果甘草G. squamulosa Franch.亲缘较接近。结论 刺果甘草存在低杂合和重复序列较多的特点,为了更好地对全基因组进行序列拼接和组装,可尝试采用三代测序结合二代测序的分析策略进行基因组组装;刺果甘草叶绿体全基因组比对和系统发育分析,为后续开展甘草属遗传多样性研究和分子鉴定标记筛选提供了重要依据。  相似文献   
33.
34.
The purpose of this study was to provide an evidence base for colorectal cancer research activity that might influence policy, mainly at the national level. Improvements in healthcare delivery have lengthened life expectancy, but within a situation of increased cancer incidence. The disease burden of CRC has risen significantly, particularly in Africa, Asia and Latin America. Research is key to its control and reduction, but few studies have delineated the volume and funding of global research on CRC. We identified research papers in the Web of Science (WoS) from 2007 to 2021, and determined the contributions of the leading countries, the research domains studied, and their sources of funding. We identified 62 716 papers, representing 5.7% of all cancer papers. This percentage was somewhat disproportionate to the disease burden (7.7% in 2015), especially in Eastern Europe. International collaboration increased over the time period in almost all countries except in China. Genetics, surgery and prognosis were the leading research domains. However, research on palliative care and quality-of-life in CRC was lacking. In Western Europe, the main funding source was the charity sector, particularly in the UK, but in most other countries government played the leading role, especially in China and the USA. There was little support from industry. Several Asian countries provided minimal contestable funding, which may have reduced the impact of their CRC research. Certain countries must perform more CRC research overall, especially in domains such as screening, palliative care and quality-of-life. The private-non-profit sector should be an alternative source of support.  相似文献   
35.
36.
BackgroundThe growing enthusiasm for the use of reverse shoulder arthroplasty (RSA) in the treatment of primary glenohumeral osteoarthritis (GHOA) with an intact rotator cuff is based on data derived from single-center studies with limited generalizability and follow-up. This study compared patient-reported outcomes (PROs) between RSA and total shoulder arthroplasty (TSA) for the treatment of primary GHOA with up to 5-year follow-up and examined temporal trends in the treatment of GHOA between 2012 and 2021.MethodsA retrospective review was performed on patients with primary GHOA undergoing primary arthroplasty surgery from the Surgical Outcomes System global registry between 2012 and 2021. PROs including the American Shoulder and Elbow Surgeons (ASES) score, Single Assessment Numeric Evaluation (SANE) score, and visual analog scale (VAS) for pain were compared between RSA and TSA at 1, 2, and 5 years postoperatively.ResultsA total of 4451 patients were included, with 2693 (60.5%) undergoing TSA and 1758 (39.5%) undergoing RSA. Both RSA and TSA provided clinically excellent outcomes at 1 year postoperatively (ASES: 80.8 ± 17.9 vs. 85.9 ± 15.2, respectively; SANE: 74.8 ± 24.7 vs. 79.5 ± 22.9; VAS pain: 1.3 ± 2.0 vs. 1.1 ± 1.7; all P < .05) that were maintained at 2 years (ASES: 81.3 ± 19.3 vs. 87.3 ± 14.9; SANE: 74.8 ± 26.2 vs. 79.7 ± 24.7; VAS pain: 1.3 ± 2.1 vs. 1.0 ± 1.6; all P < .05) and 5 years (ASES: 81.7 ± 16.5 vs. 86.9 ± 15.3; SANE: 71.6 ± 28.5 vs. 78.2 ± 25.9; VAS pain: 1.0 ± 1.7 vs. 1.0 ± 1.7; all P < .05), with statistical significance favoring TSA. After controlling for age and sex, there was an adjusted difference of 4.5 units in the ASES score favoring TSA (P = .005) at 5 years postoperatively but no differences in adjusted SANE (P = .745) and VAS pain (P = .332) scores. The use of RSA for GHOA grew considerably over time, from representing only 17% of all replacements performed for GHOA in 2012 to nearly half (47%) in 2021 (P < .001).ConclusionRSA as a treatment for GHOA with an intact rotator cuff seems to yield PROs that are largely clinically equivalent to TSA extending to 5 years postoperatively. The observed statistical significance favoring TSA appears to be of marginal clinical benefit based on established minimal clinically important differences and may be a result of the large sample size. Further research using more granular clinical data and examining differences in range of motion and complications is warranted as it may change the value analysis.  相似文献   
37.
目的 Dof(DNA binding with one finger)家族是高等植物中特有的一类转录因子家族,参与植物中光、激素、非生物胁迫等多种胁迫响应调控。本研究基于全基因组数据对黄花蒿Dof(AaDof)转录因子家族进行鉴定及表达模式分析,探究Dof家族基因在青蒿素合成调控中的作用。方法 经PFAM数据库鉴定获得AaDof序列,通过生物信息学软件分析其理化性质、亚细胞定位、基因结构、蛋白保守结构以及启动子序列结合元件等,并基于赤霉素(Gibberellic acid, GA)、紫外线B(UV-B)及二者协同胁迫下黄花蒿转录组数据对其表达模式进行分析。结果 本研究从全基因组水平共鉴定出51个AaDof基因,均含有保守的C2-C2单锌指结构,依据系统发育分析分为8个亚族,同一亚族内基因结构与蛋白保守结构域相对保守。亚细胞定位预测显示12个AaDof蛋白定位在细胞外,其余均定位在细胞核。启动子元件分析发现AaDof家族基因启动子区富含光、激素等多种响应元件。对AaDof在GA、UV-B和GA+UV-B处理下的表达模式分析发现,AaDof基因对GA胁迫处理响应较弱,仅有少量基因敏感,其表达主要受到UV-B胁迫影响。C1及C2.1亚族大部分基因在UV-B胁迫下上调表达,而A亚族大部分基因在UV-B胁迫下下调表达。qRT-PCR验证表明AaDof1AaDof17AaDof44在GA和UV-B处理下表达量显著上调,推测其可能通过参与GA和UV-B调控网络,正向调控青蒿素生物合成。结论 本研究系统鉴定了黄花蒿AaDof家族基因并筛选了3个可能正向调控青蒿素生物合成的候选AaDof基因,为黄花蒿Dof家族基因功能研究及其在青蒿素生物合成中的调控机制解析奠定基础。  相似文献   
38.
Prevention Science - This study aimed to evaluate the effectiveness of the drug and violence resistance educational program (PROERD) on short-term secondary outcomes, such as intentions to use...  相似文献   
39.
40.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号